drugset / Trial / NCT02137746

Study to Allow for Second Treatment Cycle of DCVAC in Patients With Localized Prostate Cancer

NCT02137746

Phase 2 Completed 24 enrolled SOTIO a.s.
NaSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to assess the safety of the second cycle of DCVAC/PCa in patients who completed the first cycle of DCVAC/PCa in the clinical trial SP003 without an objective progression of the disease.

Timeline

Start
2013-12
Primary completion
2015-04
Completion
2017-03-20

Drugs

EvaluationDrugModalityDoseRoute
Subject STAPULDENCEL Vaccine

Indications